Procalcitonin for the clinical laboratory: a review

&NA; Procalcitonin measurement has been claimed as a helpful marker in bacterial infection and sepsis. It has obtained FDA approval and is now widely marketed in the United States and Europe. This review summarises the current assays available, the evidence for its use and possible future applications of the assay.

[1]  J. White,et al.  Serum calcitonin precursors in sepsis and systemic inflammation. , 1998, The Journal of clinical endocrinology and metabolism.

[2]  W. Uhl,et al.  Pre-emptive antibiotic treatment vs ‘standard’ treatment in patients with elevated serum procalcitonin levels after elective colorectal surgery: a prospective randomised pilot study , 2006, Langenbeck's Archives of Surgery.

[3]  F. Signore,et al.  C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. , 2003, Clinical chemistry.

[4]  E. Ruokonen,et al.  Procalcitonin and neopterin as indicators of infection in critically ill patients , 2002, Acta anaesthesiologica Scandinavica.

[5]  G. Merlini,et al.  Procalcitonin is not a reliable marker for the assessment of severity in acute pancreatitis without infectious complications. , 2000, Clinical chemistry.

[6]  M. Christ-Crain,et al.  Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. , 2006, American journal of respiratory and critical care medicine.

[7]  C. Weenink,et al.  Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study , 2006, BMJ : British Medical Journal.

[8]  Michael F. Wilson,et al.  Procalcitonin increase after endotoxin injection in normal subjects. , 1994, The Journal of clinical endocrinology and metabolism.

[9]  J. Meis,et al.  Procalcitonin Does Not Discriminate Infection from Inflammation after Allogeneic Bone Marrow Transplantation , 2000, Clinical Diagnostic Laboratory Immunology.

[10]  K. Byth,et al.  Procalcitonin: A Marker of Bacteraemia in SIRS , 2003, Anaesthesia and intensive care.

[11]  C. Mitaka.  Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[12]  Mitchell M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.

[13]  J. E. Carceller.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis , 1992, Critical care medicine.

[14]  A. Kribben,et al.  Procalcitonin for accurate detection of infection in haemodialysis. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  M. Petric,et al.  Procalcitonin as a prognostic marker in children with meningococcal septic shock , 2002 .

[16]  N. Shafiq,et al.  Estimating the diagnostic accuracy of procalcitonin as a marker of the severity of acute pancreatitis: a meta-analytic approach. , 2005, JOP : Journal of the pancreas.

[17]  C. Hart,et al.  Procalcitonin as a diagnostic marker of meningococcal disease in children presenting with fever and a rash , 2002, Archives of disease in childhood.

[18]  A. Tenore,et al.  Procalcitonin: a marker of severity of acute pyelonephritis among children. , 2004, Pediatrics.

[19]  Usefulness of procalcitonin in neonates at risk for infection. , 1999, Clinical chemistry.

[20]  E. Giamarellos‐Bourboulis,et al.  Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient? , 2002, Intensive Care Medicine.

[21]  F. Esen,et al.  Reliability of Procalcitonin as a Severity Marker in Critically Ill Patients with Inflammatory Response , 2002, Anaesthesia and intensive care.

[22]  H. Schächinger,et al.  Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit , 2000, Critical care medicine.

[23]  U. Sungurtekin,et al.  Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit , 2002, Critical care.

[24]  Y. Tulzo,et al.  Procalcitonin: a valuable indicator of infection in a medical ICU? , 2000, Intensive Care Medicine.

[25]  E. Holler,et al.  Evaluation of C‐reactive protein, interleukin‐6, and procalcitonin levels in allogeneic hematopoietic stem cell recipients , 2006, European journal of haematology.

[26]  J. Piette,et al.  Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? , 2003, Annals of the rheumatic diseases.

[27]  K. Becker,et al.  Procalcitonin: how a hormone became a marker and mediator of sepsis. , 2001, Swiss medical weekly.

[28]  J. Coste,et al.  Procalcitonin in children admitted to hospital with community acquired pneumonia , 2001, Archives of disease in childhood.

[29]  J. Köhl,et al.  Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6 , 2000, Critical care medicine.

[30]  Andreas Bergmann,et al.  Detection of procalcitonin (PCT) in healthy controls and patients with local infection by a sensitive ILMA. , 2002, Clinical laboratory.

[31]  F. Brunkhorst,et al.  Early Identification of Biliary Pancreatitis With Procalcitonin , 1998, American Journal of Gastroenterology.

[32]  M. Chalumeau,et al.  Procalcitonine et méningites virales : réduction des traitements antibiotiques inutiles par le dosage en routine au cours d’une épidémie** , 2002 .

[33]  H. Lode,et al.  Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis , 2003, European Respiratory Journal.

[34]  F. Dressler,et al.  Increased serum procalcitonin in newborn infants without infection. , 1998, Clinical chemistry.

[35]  K. Wegscheider,et al.  Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock , 2000, Intensive Care Medicine.

[36]  K. Becker,et al.  In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue. , 2003, Endocrinology.

[37]  Dechang Chen,et al.  Serum procalcitonin and interleukin-6 levels may help to differentiate systemic inflammatory response of infectious and non-infectious origin. , 2003, Chinese medical journal.

[38]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[39]  A. Barassi,et al.  Biological variation of procalcitonin in healthy individuals. , 2004, Clinical chemistry.

[40]  I. Modrau,et al.  The Clinical Value of Procalcitonin in Early Assessment of Acute Pancreatitis , 2005, The American Journal of Gastroenterology.

[41]  A. Ganser,et al.  Diagnostic value of procalcitonin serum levels in comparison with C-reactive protein in allogeneic stem cell transplantation. , 2002, Haematologica.

[42]  G. Steinbach,et al.  The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis , 1997, Gut.

[43]  A. Gervaix,et al.  Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. , 2003, Pediatrics.

[44]  E. Papageorgiou,et al.  Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[45]  J. Mensa,et al.  Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation , 2004, British journal of haematology.

[46]  M. Christ-Crain,et al.  Procalcitonin in bacterial infections--hype, hope, more or less? , 2005, Swiss medical weekly.

[47]  J. Vincent,et al.  Procalcitonin used as a marker of infection in the intensive care unit. , 1999, Critical care medicine.

[48]  Patrick Nicolas,et al.  Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysis , 2006, Critical care medicine.

[49]  C. Mueller,et al.  Procalcitonin and the Early Diagnosis of Infective Endocarditis , 2004, Circulation.

[50]  J. Lacroix,et al.  Erratum: Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: A systematic review and meta-analysis (Clinical Infectious Diseases (July 15, 2004) 39 (206-217)) , 2005 .

[51]  R. Hetzer,et al.  Procalcitonin, A Donor-Specific Predictor of Early Graft Failure-Related Mortality After Heart Transplantation , 2001, Circulation.

[52]  C. Lasseur,et al.  Procalcitonin: a new marker of inflammation in haemodialysis patients? , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[53]  E. Yılmaz,et al.  Proinflammatory cytokines and procalcitonin in children with acute pyelonephritis , 2005, Pediatric Nephrology.

[54]  S. Madhi,et al.  Competing Interests: The phase 3 , 2022 .

[55]  M. Elsammak,et al.  DIAGNOSTIC VALUE OF SERUM PROCALCITONIN AND C-REACTIVE PROTEIN IN EGYPTIAN CHILDREN WITH STREPTOCOCCAL TONSILLOPHARYNGITIS , 2006, The Pediatric infectious disease journal.

[56]  J. White,et al.  Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. , 2004, The Journal of clinical endocrinology and metabolism.

[57]  E. Giamarellos‐Bourboulis,et al.  Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[58]  France Gauvin,et al.  Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[59]  M. Büchler,et al.  Role of procalcitonin and granulocyte colony stimulating factor in the early prediction of infected necrosis in severe acute pancreatitis , 2000, Gut.

[60]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[61]  J. Billé,et al.  Usefulness of Procalcitonin Serum Level for the Diagnosis of Bacteremia , 2001, European Journal of Clinical Microbiology and Infectious Diseases.

[62]  M. Meisner,et al.  Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction , 2004, Critical care.

[63]  B. Al-Nawas,et al.  Procalcitonin in diagnosis of severe infections. , 1996, European journal of medical research.

[64]  S. Tibby,et al.  Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leucocyte count , 1999, Archives of disease in childhood.

[65]  M. Christ-Crain,et al.  Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial , 2004, The Lancet.

[66]  S. Remes,et al.  Serum procalcitonin in pneumococcal pneumonia in children. , 2001, The European respiratory journal.

[67]  S. Looareesuwan,et al.  Serum procalcitonin levels in severe Plasmodium falciparum malaria. , 1998, The American journal of tropical medicine and hygiene.

[68]  F. Brunkhorst,et al.  Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin. , 1999, Critical care medicine.

[69]  G. Wanner,et al.  Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients , 2000, Critical care medicine.

[70]  C. Clec’h,et al.  Diagnostic and prognostic value of procalcitonin in patients with septic shock , 2004, Critical care medicine.

[71]  M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive care medicine.

[72]  P. Devos,et al.  Diagnostic and Prognostic Values of Admission Procalcitonin Levels in Community–Acquired Pneumonia in an Intensive Care Unit , 2005, Infection.

[73]  D. Pittet,et al.  Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. , 2001, American journal of respiratory and critical care medicine.

[74]  J. White,et al.  Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. , 1998, Critical care medicine.

[75]  E. Girardin,et al.  Procalcitonin is a marker of severity of renal lesions in pyelonephritis. , 1998, Pediatrics.

[76]  E. Fernández,et al.  Plasma procalcitonin and C-reactive protein concentrations in pediatric patients with Epstein-Barr virus infection. , 2003, Clinical chemistry.

[77]  J. White,et al.  Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. , 2001, The Journal of clinical endocrinology and metabolism.

[78]  F. Brunet,et al.  [Procalcitonin and viral meningitis: reduction of unnecessary antibiotics by measurement during an outbreak]. , 2002, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[79]  E. Polati,et al.  Comparison of procalcitonin and C-reactive protein as markers of sepsis. , 2003, Critical care medicine.